Latest Annual Filing
For Fiscal Year Ending Dec 31, 2021
Company Overview
Skye Bioscience Inc. is a biopharmaceutical company focused on the development of proprietary, synthetic cannabinoid derived molecules for the treatment of diseases with significant unmet needs. The company’s lead molecule, in preclinical studies, has demonstrated potential as a new class of therapy to lower intraocular pressure in patients with glaucoma or elevated intraocular pressure that is superior to currently available drugs.
IR Contacts
Company
Skye Bioscience, Inc.
11250 El Camino Real
Suite 100
San Diego, CA 92130
Investor Relations
SKYE Investor Relations
T: (858) 410-0266
ir@skyebioscience.com
Transfer Agent
ClearTrust, LLC
16540 Pointe Village Dr.
Suite 210
Lutz, FL 33558
T: 813-235-4490
www.ClearTrustOnline.com
Market Data copyright © 2022 QuoteMedia. Data delayed 15 minutes unless otherwise indicated (view delay times for all exchanges). RT=Real-Time, EOD=End of Day, PD=Previous Day. Market Data powered by QuoteMedia. Terms of Use.